Range Financial Group LLC Regeneron Pharmaceuticals, Inc. Transaction History

Range Financial Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$883.2 - $1071.19 $21,196 - $25,708	24 Added 10.08%	262 $275,000
Q1 2024 Apr 12, 2024	BUY	$902.69 - $993.35 $214,840 - $236,417	238 New	238 $229,000
Q4 2022 Jan 13, 2023	BUY	$705.89 - $766.39 $202,590 - $219,953	287 New	287 $0
Q2 2022 Jul 11, 2022	SELL	$548.35 - $738.84 $202,341 - $272,631	-369 Closed	0 $0
Q1 2022 May 18, 2022	SELL	$595.12 - $698.43 $13,687 - $16,063	-23 Reduced 5.87%	369 $258,000
Q4 2021 Jul 11, 2022	SELL	$543.48 - $670.97 $15,760 - $19,458	-29 Reduced 6.89%	392 $248,000
Q3 2021 Jul 11, 2022	BUY	$574.03 - $680.96 $5,166 - $6,128	9 Added 2.18%	421 $255,000
Q2 2021 Jul 11, 2022	BUY	$472.8 - $558.54 $194,793 - $230,118	412 New	412 $230,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Range Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Range Financial Group LLC with notifications on news.